Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Metcela Inc.

Clinicaltrial registered20 Oct 2026

Metcela Inc.

20 Oct 2026: Trial registered · Long-term Safety Study Following to JRM-001 Treatment in Pediatric Patients With Congenital Heart Disease. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
20 Oct 2026
Title
Long-term Safety Study Following to JRM-001 Treatment in Pediatric Patients With Congenital Heart Disease
Conditions
Single Ventricle, Hypoplastic Left Heart Syndrome (HLHS)
Study Type
Observational
Status
Recruiting
Countries
Japan
Country
Japan
Reference
NCT07884318
Location
Japan
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Metcela Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Japan

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.